Carboplatin/Paclitaxel/Pembrolizumab Regimen

Preferred Label : Carboplatin/Paclitaxel/Pembrolizumab Regimen;

NCIt synonyms : Carboplatin-Paclitaxel-Pembrolizumab; Carboplatin/Paclitaxel/Pembrolizumab; Carboplatin-Paclitaxel-Pembrolizumab Regimen; Carboplatin/Taxol/Keytruda;

NCIt related terms : Carboplatin and Paclitaxel (CP) and Pembrolizumab;

NCIt definition : A regimen consisting of carboplatin, paclitaxel, and pembrolizumab that can be used in the treatment of breast cancer, cervical cancer, endometrial carcinoma, head and neck cancers, and metastatic squamous non-small cell lung cancer (NSCLC). Pembrolizumab plus paclitaxel weekly/carboplatin regimen may be used for the treatment of head and neck cancers.;

NCI Metathesaurus CUI : CL936979;

Codes from synonyms : 30172;

Details

Origin ID

C157396;

UMLS CUI

C4763594;

See also (suggested by CISMeF)
- Metastatic Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Paclitaxel [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients